注意,这些药不能睡前服用!

2016-08-09 gcplive 药评中心

1.降压药大部分人的血压在生物钟作用下,通常呈“双峰状”即“匙形状”,上午8~10点达高峰随后下降、下午2~6点又会上升,随后再次下降。故一般长效降压药在早上服,短效降压药每天三次给药的,第三次应在下午6点前给药。如果在睡前服用,睡后血药浓度到达峰值,血压大幅度下降,心、脑、肾等重要器官会出现供血不足。从而使血液中的血小板、纤维蛋白等凝血物质在血管内积聚成块,阻塞脑血管,极易引发缺血性脑中风。特拉

1.降压药
大部分人的血压在生物钟作用下,通常呈“双峰状”即“匙形状”,上午8~10点达高峰随后下降、下午2~6点又会上升,随后再次下降。故一般长效降压药在早上服,短效降压药每天三次给药的,第三次应在下午6点前给药。如果在睡前服用,睡后血药浓度到达峰值,血压大幅度下降,心、脑、肾等重要器官会出现供血不足。从而使血液中的血小板、纤维蛋白等凝血物质在血管内积聚成块,阻塞脑血管,极易引发缺血性脑中风。特拉唑嗪除首剂睡前服用,以减少不良反应外,其它剂量均在清晨服用。

2.止咳药
止咳药虽能止住咳嗽,但也会造成呼吸道痰液潴留,阻塞呼吸道。另外,入睡后副交感神经兴奋性增高,导致支气管平滑肌收缩,支气管管腔变形缩小。在狭窄的管腔里,加上痰液阻塞,易出现呼吸困难等症状,影响休息。

3.利尿药
如氢氯噻嗪、环戊氯噻嗪、苄氟噻嗪、氯噻酮、安体舒通等利尿药,服后1小时左右就会发挥利尿作用,为避免反复小便可影响休息,利尿药不宜睡前服,宜在清晨空腹口服。

4.糖皮质激素
人体对激素类药的反应有时间节律。由于人体肾上腺皮质激素的分泌高峰在上午7时左右,在每天上午7时一次性给药疗效最佳。其他时间服用不良反应大,一般不宜睡前服。

5.盐类泻药
盐类泻药硫酸镁、硫酸钠的致泻作用一般于服药后4~5小时内出现,晚上用药反复腹泻可影响休息,宜采取早晨空腹口服导泻后,下午再做手术或结肠镜检查。

6.中枢兴奋剂
睡前服中枢神经兴奋剂或具有中枢神经兴奋副作用的药物,可以引起失眠。如治疗小儿多动症的药物哌甲酯等,每日最后一次药至少应在睡前4小时服用,不适合睡前服。麻黄素片、麻黄素滴鼻液及含麻黄素的复方制剂等,不适宜睡前服。

7.催吐药
一般不宜夜晚服,否则反复恶心、呕吐可影响患者休息,不利于监护,抢救意外中毒除外。

8.促胃动力药
促胃动力药如多潘立酮(吗丁啉)等宜在饭前半小时服用。夜晚不进食,胃不需要动力,促胃动力药一般只需要在白天这个时间区内给药。

9.胃肠解痉药
有资料报道,两餐之间口服匹维溴铵后出现胃灼热和吞咽困难,内镜检查显示有急性的食管溃疡形成,停药即恢复。因此,匹维溴铵应整片吞服,切勿掰碎、咀嚼或含化药片,同时宜进餐时服用,不宜睡前吞服。

10.刺激性大的药物
四环素、米诺环素、维生素C、硫酸亚铁等溶解出来的酸性物质,可腐蚀了食管黏膜,产生糜烂,甚至溃疡。氯化钾、非甾体类抗炎药、奎尼丁、活性钙(多以氢氧化钙为主)等药也能引起食管溃疡,不宜服完药就平躺睡觉,更不宜躺着服药。

11.降糖药
降糖药给药时间与进餐的关系密切,预防餐后高血糖,吃药必须按时进食,否则引起低血糖等不良反应。因此,一般不适宜睡前服用降糖药。

12.抗抑郁药
氟西汀(百优解)、氟哌噻吨美利曲辛片(黛力新)夜间服用可能影响睡眠,故不宜睡前服,每天最后一次服药不应晚于下午4点。马普替林用于维持治疗抑郁症老年人时仍以分次服药为宜,不宜在晚间睡前单次服药,防止出现睡眠障碍、焦虑。

13.抗结核药
利福平、利福喷汀等一般清晨饭前一个小时服用。但利福平等与异烟肼同时在早晨服用可使利福平半衰期缩短,利福平可诱导体内各种功能的氧化酶活性,而增加异烟肼对肝脏的毒性作用。因此,二药应该分开服用,即清晨空腹利福平,晚上服异烟肼,对肝脏的毒性作用较小。

14.消炎镇痛药
消炎镇痛药用于缓解疼痛,一般应该清晨服用,充分发挥药效而保证工作与活动不受疼痛的影响,如奥沙普秦(诺德伦)用于治疗类风湿关节炎、骨性关节炎应该清晨顿服。

15.其它药
人参、鹿茸等滋补品与维生素类,及营养药如氨基酸型肠内营养剂(高能要素)、整蛋白型肠内营养剂(能全素)、短肽型肠内营养剂(百普力)、复方α-酮酸(开同)、复方氨基酸口服液,一般应该清晨空腹服用,有利于药物的吸收。

相关会议推荐
2016天然药物研讨会:http://www.bioon.com/z/2016natural-products/Index.shtml


版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1548028, encodeId=a57e15480282f, content=<a href='/topic/show?id=175ee2964f6' target=_blank style='color:#2F92EE;'>#睡前#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72964, encryptionId=175ee2964f6, topicName=睡前)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e40613986188, createdName=ms6323715314570549, createdTime=Thu Aug 11 01:05:00 CST 2016, time=2016-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=97208, encodeId=8cf19e20818, content=科学合理用药, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b2141684904, createdName=随缘, createdTime=Wed Aug 10 06:31:00 CST 2016, time=2016-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=97184, encodeId=5f519e1848c, content=学习了,避免乱用, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73441710184, createdName=明崖, createdTime=Wed Aug 10 04:11:00 CST 2016, time=2016-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=97160, encodeId=87159e160ce, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Tue Aug 09 22:44:00 CST 2016, time=2016-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=97074, encodeId=883c9e0744f, content=继续学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Tue Aug 09 18:27:00 CST 2016, time=2016-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=97073, encodeId=8e749e07312, content=继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Tue Aug 09 18:26:00 CST 2016, time=2016-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=97046, encodeId=79d99e04630, content=了解一下!, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Tue Aug 09 17:18:00 CST 2016, time=2016-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=97028, encodeId=3b409e02804, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Tue Aug 09 15:42:00 CST 2016, time=2016-08-09, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1548028, encodeId=a57e15480282f, content=<a href='/topic/show?id=175ee2964f6' target=_blank style='color:#2F92EE;'>#睡前#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72964, encryptionId=175ee2964f6, topicName=睡前)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e40613986188, createdName=ms6323715314570549, createdTime=Thu Aug 11 01:05:00 CST 2016, time=2016-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=97208, encodeId=8cf19e20818, content=科学合理用药, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b2141684904, createdName=随缘, createdTime=Wed Aug 10 06:31:00 CST 2016, time=2016-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=97184, encodeId=5f519e1848c, content=学习了,避免乱用, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73441710184, createdName=明崖, createdTime=Wed Aug 10 04:11:00 CST 2016, time=2016-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=97160, encodeId=87159e160ce, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Tue Aug 09 22:44:00 CST 2016, time=2016-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=97074, encodeId=883c9e0744f, content=继续学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Tue Aug 09 18:27:00 CST 2016, time=2016-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=97073, encodeId=8e749e07312, content=继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Tue Aug 09 18:26:00 CST 2016, time=2016-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=97046, encodeId=79d99e04630, content=了解一下!, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Tue Aug 09 17:18:00 CST 2016, time=2016-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=97028, encodeId=3b409e02804, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Tue Aug 09 15:42:00 CST 2016, time=2016-08-09, status=1, ipAttribution=)]
    2016-08-10 随缘

    科学合理用药

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1548028, encodeId=a57e15480282f, content=<a href='/topic/show?id=175ee2964f6' target=_blank style='color:#2F92EE;'>#睡前#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72964, encryptionId=175ee2964f6, topicName=睡前)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e40613986188, createdName=ms6323715314570549, createdTime=Thu Aug 11 01:05:00 CST 2016, time=2016-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=97208, encodeId=8cf19e20818, content=科学合理用药, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b2141684904, createdName=随缘, createdTime=Wed Aug 10 06:31:00 CST 2016, time=2016-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=97184, encodeId=5f519e1848c, content=学习了,避免乱用, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73441710184, createdName=明崖, createdTime=Wed Aug 10 04:11:00 CST 2016, time=2016-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=97160, encodeId=87159e160ce, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Tue Aug 09 22:44:00 CST 2016, time=2016-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=97074, encodeId=883c9e0744f, content=继续学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Tue Aug 09 18:27:00 CST 2016, time=2016-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=97073, encodeId=8e749e07312, content=继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Tue Aug 09 18:26:00 CST 2016, time=2016-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=97046, encodeId=79d99e04630, content=了解一下!, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Tue Aug 09 17:18:00 CST 2016, time=2016-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=97028, encodeId=3b409e02804, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Tue Aug 09 15:42:00 CST 2016, time=2016-08-09, status=1, ipAttribution=)]
    2016-08-10 明崖

    学习了,避免乱用

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1548028, encodeId=a57e15480282f, content=<a href='/topic/show?id=175ee2964f6' target=_blank style='color:#2F92EE;'>#睡前#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72964, encryptionId=175ee2964f6, topicName=睡前)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e40613986188, createdName=ms6323715314570549, createdTime=Thu Aug 11 01:05:00 CST 2016, time=2016-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=97208, encodeId=8cf19e20818, content=科学合理用药, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b2141684904, createdName=随缘, createdTime=Wed Aug 10 06:31:00 CST 2016, time=2016-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=97184, encodeId=5f519e1848c, content=学习了,避免乱用, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73441710184, createdName=明崖, createdTime=Wed Aug 10 04:11:00 CST 2016, time=2016-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=97160, encodeId=87159e160ce, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Tue Aug 09 22:44:00 CST 2016, time=2016-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=97074, encodeId=883c9e0744f, content=继续学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Tue Aug 09 18:27:00 CST 2016, time=2016-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=97073, encodeId=8e749e07312, content=继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Tue Aug 09 18:26:00 CST 2016, time=2016-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=97046, encodeId=79d99e04630, content=了解一下!, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Tue Aug 09 17:18:00 CST 2016, time=2016-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=97028, encodeId=3b409e02804, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Tue Aug 09 15:42:00 CST 2016, time=2016-08-09, status=1, ipAttribution=)]
    2016-08-09 忠诚向上

    好好学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1548028, encodeId=a57e15480282f, content=<a href='/topic/show?id=175ee2964f6' target=_blank style='color:#2F92EE;'>#睡前#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72964, encryptionId=175ee2964f6, topicName=睡前)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e40613986188, createdName=ms6323715314570549, createdTime=Thu Aug 11 01:05:00 CST 2016, time=2016-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=97208, encodeId=8cf19e20818, content=科学合理用药, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b2141684904, createdName=随缘, createdTime=Wed Aug 10 06:31:00 CST 2016, time=2016-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=97184, encodeId=5f519e1848c, content=学习了,避免乱用, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73441710184, createdName=明崖, createdTime=Wed Aug 10 04:11:00 CST 2016, time=2016-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=97160, encodeId=87159e160ce, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Tue Aug 09 22:44:00 CST 2016, time=2016-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=97074, encodeId=883c9e0744f, content=继续学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Tue Aug 09 18:27:00 CST 2016, time=2016-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=97073, encodeId=8e749e07312, content=继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Tue Aug 09 18:26:00 CST 2016, time=2016-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=97046, encodeId=79d99e04630, content=了解一下!, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Tue Aug 09 17:18:00 CST 2016, time=2016-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=97028, encodeId=3b409e02804, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Tue Aug 09 15:42:00 CST 2016, time=2016-08-09, status=1, ipAttribution=)]
    2016-08-09 doctorJiangchao

    继续学习

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1548028, encodeId=a57e15480282f, content=<a href='/topic/show?id=175ee2964f6' target=_blank style='color:#2F92EE;'>#睡前#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72964, encryptionId=175ee2964f6, topicName=睡前)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e40613986188, createdName=ms6323715314570549, createdTime=Thu Aug 11 01:05:00 CST 2016, time=2016-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=97208, encodeId=8cf19e20818, content=科学合理用药, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b2141684904, createdName=随缘, createdTime=Wed Aug 10 06:31:00 CST 2016, time=2016-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=97184, encodeId=5f519e1848c, content=学习了,避免乱用, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73441710184, createdName=明崖, createdTime=Wed Aug 10 04:11:00 CST 2016, time=2016-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=97160, encodeId=87159e160ce, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Tue Aug 09 22:44:00 CST 2016, time=2016-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=97074, encodeId=883c9e0744f, content=继续学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Tue Aug 09 18:27:00 CST 2016, time=2016-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=97073, encodeId=8e749e07312, content=继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Tue Aug 09 18:26:00 CST 2016, time=2016-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=97046, encodeId=79d99e04630, content=了解一下!, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Tue Aug 09 17:18:00 CST 2016, time=2016-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=97028, encodeId=3b409e02804, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Tue Aug 09 15:42:00 CST 2016, time=2016-08-09, status=1, ipAttribution=)]
    2016-08-09 doctorJiangchao

    继续关注

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1548028, encodeId=a57e15480282f, content=<a href='/topic/show?id=175ee2964f6' target=_blank style='color:#2F92EE;'>#睡前#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72964, encryptionId=175ee2964f6, topicName=睡前)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e40613986188, createdName=ms6323715314570549, createdTime=Thu Aug 11 01:05:00 CST 2016, time=2016-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=97208, encodeId=8cf19e20818, content=科学合理用药, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b2141684904, createdName=随缘, createdTime=Wed Aug 10 06:31:00 CST 2016, time=2016-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=97184, encodeId=5f519e1848c, content=学习了,避免乱用, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73441710184, createdName=明崖, createdTime=Wed Aug 10 04:11:00 CST 2016, time=2016-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=97160, encodeId=87159e160ce, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Tue Aug 09 22:44:00 CST 2016, time=2016-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=97074, encodeId=883c9e0744f, content=继续学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Tue Aug 09 18:27:00 CST 2016, time=2016-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=97073, encodeId=8e749e07312, content=继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Tue Aug 09 18:26:00 CST 2016, time=2016-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=97046, encodeId=79d99e04630, content=了解一下!, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Tue Aug 09 17:18:00 CST 2016, time=2016-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=97028, encodeId=3b409e02804, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Tue Aug 09 15:42:00 CST 2016, time=2016-08-09, status=1, ipAttribution=)]
    2016-08-09 1dd8c52fm63(暂无匿称)

    了解一下!

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1548028, encodeId=a57e15480282f, content=<a href='/topic/show?id=175ee2964f6' target=_blank style='color:#2F92EE;'>#睡前#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72964, encryptionId=175ee2964f6, topicName=睡前)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e40613986188, createdName=ms6323715314570549, createdTime=Thu Aug 11 01:05:00 CST 2016, time=2016-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=97208, encodeId=8cf19e20818, content=科学合理用药, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b2141684904, createdName=随缘, createdTime=Wed Aug 10 06:31:00 CST 2016, time=2016-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=97184, encodeId=5f519e1848c, content=学习了,避免乱用, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73441710184, createdName=明崖, createdTime=Wed Aug 10 04:11:00 CST 2016, time=2016-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=97160, encodeId=87159e160ce, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Tue Aug 09 22:44:00 CST 2016, time=2016-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=97074, encodeId=883c9e0744f, content=继续学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Tue Aug 09 18:27:00 CST 2016, time=2016-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=97073, encodeId=8e749e07312, content=继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Tue Aug 09 18:26:00 CST 2016, time=2016-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=97046, encodeId=79d99e04630, content=了解一下!, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Tue Aug 09 17:18:00 CST 2016, time=2016-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=97028, encodeId=3b409e02804, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Tue Aug 09 15:42:00 CST 2016, time=2016-08-09, status=1, ipAttribution=)]
    2016-08-09 忠诚向上

    好好学习

    0

相关资讯

46个全球药企畅销品种名单

以下146个品种销售额数据来自美国《制药经理人》杂志及全球医药市场研究机构EvaluatePharma(单位:百万美元),来自2015年全球市场销售数据,很多是年销售额超过10亿美金以上的重磅炸弹药物,可以看出有的品种在国内卖的不好,但是在国际上销量很火。另外,个别药物是两个企业联合销售的,分别归类在各家企业里。

小道]重磅抢先!CFDA拟发布《关于进一步加强药品生产工艺监管的公告》

内容来自:不愿透露姓名网友 注:这只是草稿,,正式稿请以国家局最终发布的为准! 希望这次是国家局为药企给一个改正的机会,解决注册工艺与实际工艺不一致的老大难问题。作为药品生产企业,对于这种政策机会,绝对不能放过! 关于进一步加强药品生产工艺监管的公告 根据药品监督检查信息,部分药品生产企业存在不按照食品药品监管部门核准的生产工艺生产药品的问题。为进一步规范药品生产秩序,解决药品生产

我国将加强药品反垄断 遏制“商量涨”“任性涨”

继白酒、奶粉和汽车之后,我国的反垄断之剑将指向医药等百姓关心的领域。国家发展改革委价格监督检查与反垄断局副局长卢延纯在上海表示,下一步我国将加强药品反垄断,遏制药品价格“商量涨”“任性涨”等违反《反垄断法》的行为。 卢延纯是在近日上海举办的医药企业培训会上做上述表述的。他表示,医药产品事关人民群众生命健康,是反垄断部门关注的重点。我国药品长期实行政府定价,2015年刚刚放开。除了麻醉药品、精

5月哪些药品收到了FDA警告

2016年5月FDA共发布7项警告。

来自毒品的药品有望上市:大麻二酚第二个罕见癫痫病显示疗效

GW Pharma宣布其大麻二酚(CBD)液体制剂Epidiolex在一个叫做Lennox-Gastaut症(LGS)的罕见儿童病的三期临床试验中显示积极疗效。在这个171人参与的试验中,Epidiolex降低44%每月癫痫发病。而安慰剂只降低22%。这些病人中值年龄15岁,平均使用三种抗癫痫药物。86%的患者使用Epidiolex出现不良反应,但安慰组也有69%的患者出现不良反应。另一个22

《药品注册管理办法》9年后最重大修改(附修订稿 VS 2007版)

7月25日,CFDA通过官网发布《药品注册管理办法(修订稿)》,向社会公开征求意见,时间为一个月。关于此修改稿的意见可于8月26日之前反馈给CFDA。时隔九年,与上一版2007年《药品注册管理办法》相比较,中国医药行业的情况发生了巨大的变化,药品注册管理工作的流程和范围需要进行与时俱进的重新调整:两万件药品注册申请积压待审,运动式的削峰药审无法真正改变这种积压的现状;药品僵尸文号盛行,如何从注